Your browser doesn't support javascript.
loading
Control and treatment of type 2 diabetes in private patients in the Egyptian "DIACONTROL study".
Khattab, M; Assaad-Khalil, S; Elibrashy, I; Khalifa, A; Amara, F; Elgayyar, H; Elkafrawy, N; George, S; Ghanem, Y; Hafez, S; Shereiba, N.
Afiliación
  • Khattab M; Faculty of Medicine, Cairo University, Cairo, Egypt. samir.assaadkhalil@alexmed.edu.eg.
Eur Rev Med Pharmacol Sci ; 27(23): 11421-11432, 2023 Dec.
Article en En | MEDLINE | ID: mdl-38095390
ABSTRACT

OBJECTIVE:

This study aims to identify the characteristics of Egyptian patients suffering from type 2 diabetes mellitus (T2DM), determine disease control rates, and gain insights into clinical treatments. PATIENTS AND

METHODS:

A total of 2,516 patients with T2DM were recruited from 244 private clinics across Egypt in a one-month period from May to June 2017. Data collected from patients included glycemic control parameters of glycosylated hemoglobin, fasting plasma glucose, and postprandial glucose. Additional information gathered included patients' weight, age, level of physical activity, smoking habits, presence of comorbidities, type of treatment received for type 2 diabetes, number and severity of hypoglycemic events, as well as treatment modification by the physician in the last visit. The type of statistics used for the analysis is descriptive statistics and regression model.

RESULTS:

Only 18.4% of participating patients achieved the target level of glycosylated hemoglobin of 7% or below. The mean age of these patients was 54±11.2 years, and the mean duration since the first diagnosis was 6.6±6.4 years. A total of 33.4% of all patients had no known comorbidity, while the rest had one or more known and treated comorbidities. A total of 76% of patients received sulfonylurea either as monotherapy or in combination with other treatments. In addition, no treatment modifications or adjustments were provided for 32% of the study participants who did not reach their glycemic control target.

CONCLUSIONS:

In Egypt, there is a low rate of glycemic control among private patients and a high prevalence of comorbid conditions. This is likely to cause a significant health burden to people with T2DM, the healthcare system, and the economy due to a loss in productivity. This study presented an argument for better-managed measures to improve glycemic control in the population, such as patient education to increase patient awareness and adherence to treatment protocols as well as improved adherence to guidelines by clinicians.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Límite: Adult / Aged / Humans / Middle aged País/Región como asunto: Africa Idioma: En Revista: Eur Rev Med Pharmacol Sci Asunto de la revista: FARMACOLOGIA / TOXICOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Egipto

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Límite: Adult / Aged / Humans / Middle aged País/Región como asunto: Africa Idioma: En Revista: Eur Rev Med Pharmacol Sci Asunto de la revista: FARMACOLOGIA / TOXICOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Egipto